D Bracy

2.1k total citations
17 papers, 1.6k citations indexed

About

D Bracy is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, D Bracy has authored 17 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in D Bracy's work include Multiple Myeloma Research and Treatments (15 papers), Cancer therapeutics and mechanisms (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). D Bracy is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Cancer therapeutics and mechanisms (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). D Bracy collaborates with scholars based in United States. D Bracy's co-authors include Guido Tricot, Sundar Jagannath, Bart Barlogie, S. Naucke, John Crowley, S. Mattox, K.R. Desikan, David S. Siegel, Bruce D. Cheson and David H. Vesole and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Statistics in Medicine.

In The Last Decade

D Bracy

17 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Bracy United States 14 1.5k 874 692 204 132 17 1.6k
Firas Muwalla United States 11 1.2k 0.8× 970 1.1× 556 0.8× 190 0.9× 93 0.7× 13 1.4k
Brigitte Pegourié France 16 1.6k 1.1× 1.1k 1.3× 909 1.3× 310 1.5× 100 0.8× 49 1.7k
A. John Ashcroft United Kingdom 16 949 0.7× 663 0.8× 913 1.3× 156 0.8× 190 1.4× 23 1.5k
Dan Spoon United States 9 1.3k 0.9× 854 1.0× 671 1.0× 171 0.8× 76 0.6× 11 1.4k
Matthew Jenner United Kingdom 23 1.4k 0.9× 1.3k 1.5× 755 1.1× 200 1.0× 92 0.7× 86 1.8k
Anne‐Marie Stoppa France 19 1.2k 0.8× 756 0.9× 592 0.9× 141 0.7× 216 1.6× 54 1.4k
Huaibao Feng United States 13 1.1k 0.8× 859 1.0× 796 1.2× 229 1.1× 134 1.0× 30 1.4k
Himal Amin United States 8 1.1k 0.7× 870 1.0× 685 1.0× 197 1.0× 138 1.0× 13 1.4k
M Tribalto Italy 18 1.0k 0.7× 629 0.7× 515 0.7× 237 1.2× 141 1.1× 47 1.3k
Andrew Cakana United States 20 1.5k 1.0× 1.4k 1.6× 948 1.4× 299 1.5× 47 0.4× 48 1.9k

Countries citing papers authored by D Bracy

Since Specialization
Citations

This map shows the geographic impact of D Bracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Bracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Bracy more than expected).

Fields of papers citing papers by D Bracy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Bracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Bracy. The network helps show where D Bracy may publish in the future.

Co-authorship network of co-authors of D Bracy

This figure shows the co-authorship network connecting the top 25 collaborators of D Bracy. A scholar is included among the top collaborators of D Bracy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Bracy. D Bracy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rolka, Henry, et al.. (2005). Using simulation to assess the sensitivity and specificity of a signal detection tool for multidimensional public health surveillance data. Statistics in Medicine. 24(4). 551–562. 21 indexed citations
2.
Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone. 1101–11071. 1 indexed citations
3.
Desikan, K.R., Bart Barlogie, Sundar Jagannath, et al.. (1998). Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.. Journal of Clinical Oncology. 16(4). 1547–1553. 135 indexed citations
4.
Desikan, K.R., Sundar Jagannath, David S. Siegel, et al.. (1998). Collection of More Hematopoietic Progenitor Cells with Large Volume Leukapheresis in Patients with Multiple Myeloma. Leukemia & lymphoma. 28(5-6). 501–508. 20 indexed citations
5.
Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplantation. 21(11). 1101–1107. 39 indexed citations
6.
Zent, Clive S., Carla S. Wilson, Guido Tricot, et al.. (1998). Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation. Blood. 91(9). 3518–3523. 5 indexed citations
7.
Zent, Clive S., Carla S. Wilson, Guido Tricot, et al.. (1998). Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation. Blood. 91(9). 3518–3523. 88 indexed citations
8.
Mehta, Jayesh, Guido Tricot, Sundar Jagannath, et al.. (1997). High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant. Bone Marrow Transplantation. 20(2). 113–116. 8 indexed citations
9.
Vesole, DH, et al.. (1997). Peripheral stem cell mobilization and engraftment in patients over age 60. Bone Marrow Transplantation. 20(1). 1–3. 22 indexed citations
10.
Tricot, Guido, Jeffrey R. Sawyer, Sundar Jagannath, et al.. (1997). Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.. Journal of Clinical Oncology. 15(7). 2659–2666. 138 indexed citations
11.
Jagannath, Sundar, K.R. Desikan, Madanahalli R Jagannath, et al.. (1997). Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplantation. 20(6). 445–450. 77 indexed citations
12.
Barlogie, Bart, Sundar Jagannath, David H. Vesole, et al.. (1997). Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma. Blood. 89(3). 789–793. 415 indexed citations
13.
Vesole, DH, Guido Tricot, S Jagannath, et al.. (1996). Autotransplants in multiple myeloma: what have we learned?. Blood. 88(3). 838–847. 117 indexed citations
14.
Tricot, Guido, Sundar Jagannath, David H. Vesole, et al.. (1996). Hematopoietic Stem Cell Transplants for Multiple Myeloma. Leukemia & lymphoma. 22(1-2). 25–36. 14 indexed citations
15.
Vesole, DH, Guido Tricot, Sundar Jagannath, et al.. (1996). Autotransplants in multiple myeloma: what have we learned?. Blood. 88(3). 838–847. 95 indexed citations
16.
Tricot, Guido, David S. Alberts, Cynthia S. Johnson, et al.. (1996). Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.. PubMed. 2(6). 947–52. 94 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Firas Muwalla Breakdown of academic impact, for papers by Brigitte Pegourié Breakdown of academic impact, for papers by A. John Ashcroft Breakdown of academic impact, for papers by Dan Spoon Breakdown of academic impact, for papers by Matthew Jenner Breakdown of academic impact, for papers by Anne‐Marie Stoppa Breakdown of academic impact, for papers by Huaibao Feng Breakdown of academic impact, for papers by Himal Amin Breakdown of academic impact, for papers by M Tribalto Breakdown of academic impact, for papers by Andrew Cakana
Rankless by CCL
2026